Renal Anemia - Conflicts and Controversies (Hardcover, 2002 ed.)

Is the nephrology community facilitating excess cardiovascular deaths in patients with kidney failure and anemia by treating to a subnormal hematocrit? Why have clinicians and nephrologists permitted health insurance companies and the government to decide when anemia therapy should begin in persons with progressive kidney failure? Is iron the only variable that can be manipulated to maximize response to recombinant erythropoietin? Are we using too much intravenous iron in kidney failure patients, and is oral iron supplementation worthless in sustaining iron stores during long-term erythropoietin treatment? When does left ventricular hypertrophy begin to emerge in patients with progressive renal disease and is there convincing evidence that anemia is a significant cause of LVH in this setting? Is darbepoetin alfa, a new novel, long-acting erythropoietin, really superior to recombinant erythropoietin? This book is a compilation of proceedings from a conference in Brooklyn convened to address these and other controversial and unresolved issues in renal anemia management.

General

Imprint:	Springer-Verlag New York
Country of origin:	United States
Release date:	July 2002
First published:	July 2002
Editors:	Onyekachi Ifudu
Dimensions:	235 x 155 x 11mm (L x W x T)
Format:	Hardcover
Pages:	145
Edition:	2002 ed.
ISBN-13:	978-1-4020-0678-4
Categories:	Books > Medicine > Clinical & internal medicine > Haematology Books > Medicine > Clinical & internal medicine > Renal medicine > General Promotions
LSN:	1-4020-0678-0
Barcode:	9781402006784

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!